GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » 3-Year EBITDA Growth Rate

ImmunoPrecise Antibodies (STU:TQB) 3-Year EBITDA Growth Rate : -111.70% (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies 3-Year EBITDA Growth Rate?

ImmunoPrecise Antibodies's EBITDA per Share for the three months ended in Jan. 2025 was €-0.47.

During the past 3 years, the average EBITDA Per Share Growth Rate was -111.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -62.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of ImmunoPrecise Antibodies was 71.70% per year. The lowest was -201.00% per year. And the median was 3.70% per year.


Competitive Comparison of ImmunoPrecise Antibodies's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, ImmunoPrecise Antibodies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImmunoPrecise Antibodies's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's 3-Year EBITDA Growth Rate falls into.


;
;

ImmunoPrecise Antibodies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


ImmunoPrecise Antibodies  (STU:TQB) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


ImmunoPrecise Antibodies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

ImmunoPrecise Antibodies Headlines

No Headlines